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ABSTRACT
Transfer RNAs (tRNAs) are central to protein synthe-
sis and impact translational speed and fidelity by
their abundance. Here we examine the extent to
which viruses manipulate tRNA populations to
favor translation of their own genes. We study two
very different viruses: influenza A virus (IAV), a
medium-sized (13 kB genome) RNA virus; and
vaccinia virus (VV), a large (200 kB genome) DNA
virus. We show that the total cellular tRNA popula-
tion remains unchanged following viral infection,
whereas the polysome-associated tRNA population
changes dramatically in a virus-specific manner.
The changes in polysome-associated tRNA levels
reflect the codon usage of viral genes, suggesting
the existence of local tRNA pools optimized for viral
translation.
INTRODUCTION
Viruses are wholly dependent on the host translation
machinery to synthesize their proteins. Consequently,
viral codon usage is thought to be under selective
pressure to adapt to the host cell transfer RNA (tRNA)
pool. Since host codon usage generally reflects the host
tRNA pool (1,2), viral translation should be most efficient
when viral codon usage is similar to that of the host genes.
In many cases, however, viral codon usage seems poorly
adapted to that of its host (3–5). For example, Influenza A
viruses (IAVs) have a GC-poor genome and favor A/U-
ending codons (6,7). The reason for this codon bias
remains an open question, often approached from an evo-
lutionary perspective. Numerous studies have attributed
codon usage bias to translational selection, mutational
bias and genetic drift (8–11). Matching viral and host
codon usage can enhance translation of viral proteins
and increase immunogenicity (12–17).
Host codon usage or tRNA gene copy numbers are
frequently used as a proxy for cellular tRNA levels.
These proxies are typically highly inaccurate. tRNA
levels fluctuate based on cell type and environmental con-
ditions. For example, a study of tissue-specific tRNA ex-
pression revealed distinct widely divergent tRNA
expression patterns in all tissues examined (18). Distinct
tRNA expression patters have been reported in many
transformed cell types, including cells transformed by
viruses (19–22).
Viruses display a tremendous interest in translation,
rapidly altering a number of translational components
while shifting translation from host to viral mRNAs
(23,24). We reported that infection of cultured human
cells with adenovirus, vaccinia virus (VV) or IAV alters
tRNA acylation specificity, essentially altering the genetic
code (25). These findings prompt the question of whether
viruses also modulate tRNA populations to enhance viral
protein synthesis.
To answer this question, here we use tRNA microarray
technology to measure tRNA levels in cells infected
with two completely distinct viruses: IAV, a negative-
strand RNA virus and VV, a double-stranded DNA virus.
MATERIALS AND METHODS
Cells and infections
HeLa cells (American Type Culture Collection) were
cultured in DMEM supplemented with 7.5% FBS.
IAV infection
HeLa cells were grown to 60–70% confluency and infected
with the Influenza A/Puerto Rico/8/34 strain at a multi-
plicity of 10 in Autopow infection medium, pH 6.6. After
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adsorption at 37C for 1 h, infected monolayers were
overlaid with DMEM supplemented with 7.5% FBS and
incubated for an additional 5 h.
VV infection
HeLa cells were grown to 60–70% confluency and
infected with VV WR at a multiplicity of 10 in saline sup-
plemented with 0.1% BSA. After adsorption at 37C for
1 h, infected monolayers were overlaid with DMEM




Total RNA was extracted from HeLa cells 6 h
post-infection by the TRIzol method (Invitrogen).
Polysome RNA
HeLa cells 6 h post-infection were trypsinized in the
presence of emetine (25 mg/ml, EMD) and re-suspended
in ice-cold polysome lysis buffer (50mM Tris–HCl pH
7.5, 5mM MgCl2, 25mM KCl, 0.2M sucrose, 1%
NP-40, 10 u/ml RNaseOUT). Cell lysate was transferred
to Lysing Matrix D tubes (MP Biomedical) and vortexed
1min at 4C. The lysate was clarified by spinning 10min at
14 000 rpm at 4C. The supernatant was loaded on a
sucrose density gradient (15–50% w/v) prepared in
SW41 tubes (Beckman) and spun at 4C, 35 000 rpm for
2.5 h. Sucrose solutions were prepared in gradient buffer
(50mM Tris–HCl pH 7.5, 5mM MgCl2, 25mM KCl,
100 mg/ml cycloheximide, 10 u/ml RNaseOUT). Twenty
one fractions were collected manually from the top of
the gradient and the OD260 of each fraction measured
by nanodrop (Thermo Scientific). The polysome fractions
were pooled and centrifuged for 2 h at 40 000 rpm in
T100.1 tubes to pellet the ribosomes. Polysome RNA
was then extracted from the ribosome pellet following
the TRIzol method (Invitrogen).
tRNA microarrays
The tRNA microarray experiment consists of four steps
starting from total or polysome RNA: (i) deacylation to
remove any amino acids still attached to the tRNA;
(ii) selective fluorophore labeling of tRNA; (iii) hybridiza-
tion; and (iv) data analysis. The reproducibility of the
tRNA microarray method and result validation by
northern blots have been extensively described in previ-
ously published papers.
Deacylation
Total or polysome RNA (0.25 mg/ml) was spiked with three
tRNA transcript standards (Escherichia coli tRNALys,
E. coli tRNATyr and Saccharomyces cerevisiae tRNAPhe)
at 0.67 pmol each per mg RNA. The mixture was incubated
in 100mM Tris–HCl pH 9.0 at 37C for 30min, then
neutralized by the addition of an equal volume of 100
mM sodium acetate/acetic acid, 100mM NaCl at pH
4.8. After ethanol precipitation, deacylated RNA was
dissolved in water and its integrity verified by agarose
gel electrophoresis.
Fluorophore labeling
tRNA in each sample was selectively labeled with either
Cy3 or Alexa647 using an enzymatic ligation method pre-
viously described. The labeling oligonucleotide consists of
an 8 bp RNA:DNA hybrid helix containing a Cy3 or
Alexa647 fluorophore in the loop and an overhang com-
plementary to the 30CCA nucleotides universally
conserved in all tRNAs. The ligation reaction was
carried out overnight at 16C with 1 u/ml T4 DNA ligase
(USB Corp) and 9 mM labeling oligonucleotide.
Hybridization
1–2.5mg of labeled RNA were hybridized on com-
mercially printed custom microarrays (Microarrays Inc.).
Hybridization was performed in a DigiLab GeneMachines
Hyb4 at 60C for 16 h. Each sample array was hybridized
with an infected sample and uninfected control sample as
a reference, labeled with Cy3 or Alexa647. The control
array was hybridized with uninfected control sample
labeled with Cy3 and Alexa647.
Data analysis
Arrays were scanned using a GenePix 4000b scanner
(Axon Instruments). For both Cy3 and Alexa647, PMT
gain was set at 600 and power at 100%. These settings
were chosen to provide optimal signal without saturation.
Array images were generated and analysed using GenePix
6.0 software. GenePix adaptive circle spot segmentation
was used for image analysis. To account for differences
in labeling and hybridization efficiencies, the following
normalization procedure was applied to each probe:
(i) average Alexa647/Cy3 ratios were calculated from all
the replicate spots for each probe; (ii) the sample array
Alexa647/Cy3 ratio was normalized to the corresponding
control array Alexa647/Cy3 ratio; and (iii) the obtained
value was divided by the average of the Alexa647/Cy3
ratios of the three tRNA standards spiked in at the
deacylation step.
S35 labeling
HeLa cells were trypsinized and washed twice in
methionine-free DMEM (Invitrogen). Approximately 106
cells were incubated for 5min at 37C in methionine-free
DMEM supplemented with 0.1mCi/ml S35-methionine
(Perkin Elmer). Cells were washed twice with ice-cold
PBS supplemented with 100 mg/ml cycloheximide and
re-suspended in 500 ml lysis buffer (1X PBS, 1% NP-40,
Roche Mini Protease Inhibitor). Lysate was incubated on
ice for 15min prior to loading on a NuPAGE 10%
Bis-Tris gel (Invitrogen) or TCA precipitation. S35-
labeled products were visualized on a phosphorimager
(Typhoon, Amersham Biosciences) and analysed using
ImageJ software (http://rsbweb.nih.gov/ij/). For TCA pre-
cipitation, 5 ml of each sample was applied per spot of a
96-well filter mat (six replicates per sample). After drying
at 60C, the mat was incubated in 10% TCA for 30min at
room temperature and washed twice in 70% ethanol
(10min per wash). The mat was again dried at 60C and
placed in a scintillation bag with 5ml scintillation liquid
(Betaplate Scint, Perkin Elmer). Radioactivity was
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quantitated using a liquid scintillation counter (1450
MicroBeta Lux, Perkin Elmer).
tRNA—codon usage analysis
Relative tRNA abundance
Relative tRNA abundances were measured using the
tRNA microarray method described above. Our tRNA
microarray measurements reflect changes in tRNA abun-
dance relative to the uninfected control sample rather than
absolute tRNA abundances because (i) all arrays include
the control sample; and (ii) all data are normalized to
the control. Only tRNA isoacceptors uniquely detected
by one tRNA probe were used for tRNA—codon
usage analysis. For example, the three proline tRNA
isoacceptors are detected by a single probe on the tRNA
microarray and so were excluded from the analysis.
Codon usage
The VV WR (AY243312.1) and IAV A/Puerto Rico/8/34/
Mount Sinai (H1N1) (AF389115.1 through AF389122.1)
complete sequences were downloaded from NCBI. Coding
sequences were extracted and codon usage was calculated
using the Sequence Manipulation Suite (version 2, http://
www.bioinformatics.org/sms2/). Human codon usage for
all human genes was obtained from the Codon Usage
Database (http://www.kazusa.or.jp/codon/). Amino acids
read by only one codon (e.g. AUG for Met and UGG for
Trp) and stop codons were excluded from tRNA—codon
usage analysis.
tRNA—codon usage correlations
Viral and human codon usage were expressed as frequency
per 1000 codons. Because a given tRNA isoacceptor may
decode more than one mRNA codon (wobble), a con-
verted codon usage was used for further analysis. The
codon frequencies of all the codons decoded by a given
tRNA were added together to obtain the converted codon
usage corresponding to that tRNA. Viral converted codon
usage was normalized to human converted codon usage,
reflecting relative rather than absolute codon usage. This
normalization was necessary because the tRNA micro-
array method provides relative and not absolute tRNA
abundances (see above).
Software and data processing
Gel analysis was performed using ImageJ software (http://
rsbweb.nih.gov/ij/). All data were plotted using Prism
(Graphpad). One sample t-tests were performed using
GraphPad QuickCalcs (http://graphpad.com/quickcalcs/
OneSampleT1.cfm). To apply the Bonferroni correction,
the obtained P-values were divided by the number of
events measured.
RESULTS AND DISCUSSION
Codon usages of influenza A and VV genes differ from
human genes
Viral codon adaptation is considered poor when codons
that are infrequent in host genes are enriched in viral
genes. In this study, we used two viruses distinct from
each other in almost every aspect of their genome and
replication cycle: IAV and VV. IAV is a negative-
stranded RNA virus with a limited genome (13 kB) that
replicates its RNA in the nucleus, where it steals caps from
cellular mRNAs. VV is a double-stranded DNA virus with
a large genome that replicates in cytoplasmic viral
factories, where it imports ribosomes to produce viral
proteins (26–28).
We compared the codon usages of IAV and VV to the
codon usage of their human host (Figure 1). Codon usage
can be expressed as either frequency per 1000 codons or
relative synonymous codon usage (RSCU). Frequency per
1000 codons allows for comparison between species by
adjusting for differences in coding sequence length.
RSCU is a normalized index of codon usage that adjusts
both for coding sequence length and amino acid compos-
ition. It has a value of 0 for unused synonymous codons, a
value of 1 for equally used synonymous codons and a
maximum of n, where n is the number of synonymous
codons in the codon family. Regardless of the index
used, the codon usages of IAV and VV correlate poorly
with the codon usage of their human host. When codon
usage is expressed as frequency per 1000, the R2 correl-
ation coefficient between viral and human codon usage is
0.26 for IAV and 0.01 for VV. When codon usage is ex-
pressed as RSCU, the the R2 correlation coefficient is 0.10
for IAV and 0.08 for VV.
Analysis of tRNA abundance upon viral infection
Because host codon usage generally reflects the host tRNA
(1,2,29–31), poor viral codon adaptation is thought to
result in inefficient translation of viral genes. This
assumes that rare host tRNAs are limiting in the transla-
tion of viral genes, and that the host tRNA pool remains
unchanged after viral infection. There is extensive experi-
mental evidence supporting the first assumption. Indeed,
codon optimization has been shown to result in increased
translation and greater immunogenicity of several viruses
and bacteria (12–17). To our knowledge, however,
previous studies have not explored whether viruses alter
tRNA pools to favor translation of viral genes.
To address this question, we examined the changes in
tRNA populations after infection with IAV or VV using
tRNA microarray technology (18,21,32). For this study,
we used custom-printed microarrays containing 37 probes
for human nuclear-encoded tRNAs and 22 probes for
human mitochondrial-encoded tRNAs. The arrays
include 75 probes for S. cerevisiae tRNAs and 34 probes
for E. coli tRNAs that serve as hybridization and specifi-
city controls. We isolated total or polysome-associated
RNA from cells 6 h post-infection. After selectively
labeling tRNAs by ligation to a fluorophore-containing
oligonucleotide, we hybridized the samples directly onto
the microarray. We included an uninfected control sample
in all array hybridizations to correct for variations in
labeling and array manufacturing. The tRNA microarray
method typically measures changes in tRNA levels relative
to the control sample, so only relative tRNA levels were
analysed in this study.
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We first quantitated total nuclear- and mitochondrial-
encoded tRNAs in virus-infected and uninfected cells.
This revealed that infection with neither VV nor
IAV alters global tRNA levels (Figure 2A, left panel).
Similarly, for individual tRNA species, infection with
either virus did not significantly alter abundance
(Figure 2B, top). We conclude that cellular tRNA levels
are not greatly altered by IAV- or VV-infection.
We then examined tRNA levels in polysome-associated
RNA samples (for simplicity, polysome-associated RNA
is termed polysome RNA in the text below). Polysome
RNA was isolated from sucrose gradient polysome
fractions, and therefore contains ribosome-bound
tRNAs and tRNAs associated with aminoacyl synthetases
and other components of the translation machinery (33).
As expected, we detected only nuclear-encoded tRNAs
but no mitochondrial-encoded tRNAs in polysome RNA
samples (Figure 2A, right panel). As with cellular RNA
samples, we found no significant difference in median
polysome tRNA levels between IAV- or VV-infected
versus uninfected cells. We observed, however, significant
changes in individual polysome tRNA levels in
virus-infected compared with uninfected cells (Figure 2B,
bottom). IAV- and VV-infected cells each exhibit distinct
changes in their polysome tRNA populations compared
with uninfected control cells. For example, tRNAArg(UCU)
is most over-represented (1.6-fold) and tRNAGly(GCC/CCC)
is most under-represented (0.8-fold) in polysome RNA
of IAV-infected cells. tRNAIle(UAU) is most over-
represented (2.4-fold) and tRNAArg(CCG/UCG) is most
under-represented (0.4-fold) in polysome RNA of VV-
infected cells.
We conclude that the polysome tRNA population is
selectively and significantly altered by IAV and VV infec-
tion, in contrast to total tRNA populations, which are not
detectably altered.
tRNA—codon usage correlation analysis
IAV or VV infections alter the polysome tRNA popula-
tion, most likely as a result of viral protein synthesis at the
expense of host translation (34). To quantitate the contri-
bution of virus versus host translation, we analysed
protein synthesis 6 h post-infection by SDS-PAGE of
total lysates from cells labeled for 5min pulse with S35-
Met. This clearly revealed synthesis of major IAV or VV
proteins superimposed on major inhibition of host protein
synthesis: host shutdown was more complete with VV
(Figure 3A). IAV-infected cells exhibited a higher total
translation (1.5-fold) relative to VV-infected or uninfected
cells (Figure 3B).
To correlate polysome tRNA levels with viral codon
usage we plotted the relative tRNA levels versus
the normalized codon usage of the virus (Figure 3C).
For a given codon, the normalized codon usage is
defined as the viral codon usage divided by the human
codon usage. This normalization was necessary to allow
direct comparison to the relative tRNA levels measured by
microarray. We found that polysome tRNA levels correl-
ate remarkably well with normalized viral codon usage:
R2=0.57 for IAV and R2=0.82 for VV. The higher cor-
relation coefficient obtained with VV is consistent with a
greater proportion of viral translation relative to host
translation, clearly seen by SDS-PAGE analysis
(Figure 3A).
Viral adaptation for replication in IFN-exposed cells?
Though viral codon usage is poorly adapted to the HeLa
tRNA pool, IAV and VV do not alter cellular tRNA levels
to favor translation of their viral genes. Given the rapidity
of infectious cycles of IAV and VV and the large size of
tRNA pools (5 107 copies of tRNA per cell) it may
simply not be possible for viruses to acutely alter tRNAs
to their benefit. Viruses, however, with longer infectious
times may profit by modulating tRNA transcription to
better match viral codon usage. Indeed, van Weringh
et al. (35) proposed just this mechanism to account for
the selective incorporation of normally low abundance
tRNAs into HIV particles.
Under normal infection conditions, hosts will rapidly
produce interferons (IFNs). Later rounds of viral replica-
tion will then occur in cells reprogrammed by IFNs. We
recently reported that both type I and type II IFNs
markedly change tRNA aminoacylation levels in HeLa
cells (25). As seen in Figure 4A, IFN-g generally increases
tRNA expression, whereas IFN-b generally decreases
Figure 1. Codon usage of virus compared with human. Viral codon
usage (IAV in gray, VV in black) is plotted against human codon
usage. Codon usage is expressed as frequency per 1000 codons (top)
or RSCU (bottom). Regardless of the index used, viral codon usage
correlates poorly with human codon usage. When codon usage is ex-
pressed as frequency per 1000, the R2 correlation coefficient between
viral and human codon usage is 0.26 for IAV and 0.01 for VV. When
codon usage is expressed as RSCU, the R2 correlation coefficient is 0.10
for IAV and 0.08 for VV.
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Figure 2. Changes in tRNA abundance after viral infection. HeLa cells were infected with IAV or VV; total cellular RNA or polysome RNA was
isolated 6 h post-infection. tRNA abundance was measured by microarray relative to an uninfected control. Data are averages of three replicate
experiments; error bars indicate standard deviation. (A) Median tRNA abundance after viral infection. Median values for nuclear-encoded tRNAs
(black) and mitochondrial-encoded tRNAs (gray) are shown for IAV- and VV-infected cells relative to an uninfected control (set to 1). No
mitochondrial-encoded tRNAs were detected in the polysome RNA samples. No significant changes in median tRNA abundance are detected in
total cellular RNA (left) or polysome RNA (right). (B) Individual tRNA abundance after viral infection. Individual tRNA abundance values are
shown for IAV (gray) and VV (black) infected cells relative to an uninfected control (set to 1, black line). A value of 1 indicates no change, a value
<1 indicates a decrease and a value >1 indicates an increase after viral infection. No significant changes in individual tRNA abundances are detected
in total cellular RNA (top), but distinct and virus-specific changes are observed in polysome RNA (bottom). One sample t-tests were performed to
determine the statistical significance of the changes: * indicates P-value <0.0014 applying the Bonferroni correction for measuring multiple events
(P-value/number of events, or 0.05/37).
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tRNA expression (these data were referred to, but not
shown in (25)). For most viral codons, IFN exposure
will have little positive or negative effect in matching
cellular tRNA expression. Intriguingly, the only tRNA
species commonly upregulated by type I and II IFNs is
tRNAIle(UAU), decoding the Ile-AUA codon which is the
most overrepresented in the IAV and VV genomes
(Figure 4B and C). This result suggests that evolution
may have adapted IAV and VV Ile codons for better
translation in IFN-g-exposed cells.
CONCLUDING REMARKS
Since IAV and VV do not alter tRNA levels on the
cellular scale, an intriguing possibility is the existence of
local tRNA pools at sites of viral translation.
tRNAs decoding codons rare in the host but frequent in
the virus (such as Ile-AUA) may be recruited and re-used
in successive rounds of viral translation, becoming
enriched in the immediate environment. Such a ‘channeled
tRNA cycle’ was first proposed by Deutscher et al. over
10 years ago: tRNAs are shuttled directly from the
ribosome to their cognate tRNA synthetase and back to
the ribosome for another round of translation,
without reentering the cytosolic pool (36–38). Local
tRNA pools would therefore be adapted to viral
codon usage, enhancing translational efficiency of viral
genes.
The possibility of local tRNA pools is particularly
relevant in the case of VV, which replicates in cytoplasmic
viral factories where the components of the translation
machinery, including tRNA synthetases, are recruited
(26,33). Clearly an area of future investigation is
to study the local concentrations of individual tRNAs in
VV-factories and at other locations of clearly
compartmentalized translation. Although this can be
approached experimentally by available techniques (such
as FISH and introduction of labeled tRNAs into live
cells), further technological advances will be required to
finely discriminate between the myriad tRNA species and
increase resolution.
Figure 3. Polysome tRNAs reflect viral translation. (A) Translation patterns after viral infection. HeLa cells were infected with IAV, VV or
mock-treated for the uninfected control. At 6 h post-infection, cells were pulsed with S35-methionine and lysed. Cell lysate was loaded on an
SDS-PAGE gel for visualization of S35-labeled protein products (left). Signal intensity was quantitated to better compare the infected (IAV or
VV) and the control samples (middle and right panels). Translation is significantly altered upon viral infection. However, VV is far more efficient
than IAV in shutting down host translation (R2 IAV/Ctrl>R2 VV/Ctrl). (B) Quantitation of translation after viral infection. Cell lysate was obtained
as in (A) and S35-labeled protein products were quantitated on a scintillation counter after TCA precipitation. Values are averages of six technical
replicates, error bars indicate standard deviation. A modest increase in translation is observed in IAV-infected cells but not VV-infected cells relative
to the uninfected control. (C) tRNA—codon usage analysis. Relative tRNA abundance values after viral infection (IAV left, VV right) measured by
microarray are plotted against normalized viral codon usage. Polysome tRNA values (gray) correlate well with viral codon usage, whereas total
tRNA values (black) do not correlate with viral codon usage.
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